Directory
>
Margaret Karow
Margaret Karow
Founder and Chief Development Office | Xilio Therapeutics, Inc.
Camarillo, California, United States
Margaret Karow
Summary
Margaret Karow is a seasoned biopharmaceutical expert with over 25 years of experience in protein therapeutics development. As the Founder and Chief Development Officer at Tentarix Biotherapeutics, she has a proven track record of leading innovative projects and achieving significant funding milestones. Her previous roles include serving as the Chief Scientific Officer at Gensun Biopharma and as Senior Vice President of Pre-Clinical Development at Xilio Therapeutics, where she played a pivotal role in advancing therapeutic candidates. Margaret's extensive background includes leadership positions at Amgen, where she oversaw various departments focused on biologics and biosimilars. She began her career at Regeneron, contributing to groundbreaking work in immunology and antibody development. Known for her strategic mindset and technical expertise, Margaret is passionate about advancing therapeutic solutions in the life sciences sector.
Margaret Karow
Work Experience
Founder and Chief Development Office at
Tentarix Biotherapeutics
February 2021 - Present
Special Advisor and Scientific Advisory Board member at
Xilio Therapeutics, Inc.
September 2019 - Present
VICE PRESIDENT DISCOVERY AND PRECLINICAL DEVELOPMENT at
Akrevia Therapeutics
September 2016 - Present
Founder and Lead of Translational Biology at
Tentarix Biotherapeutics
August 2020 - February 2021
Senior Vice President of Pre-Clinical Development at
Xilio Therapeutics, Inc.
September 2016 - August 2020
Executive Director at
Amgen, Inc.
October 2014 - September 2016
Executive Director at
Amgen, Inc.
April 2006 - September 2016
Vice President at
Regeneron
January 1996 - January 2006
Immune Diseases and Antibody Therapeutics at
Regeneron Pharmaceuticals
January 1995 - January 2005
Margaret Karow
Education
University of Utah School of Medicine, Phd
January 1987 - January 1992
University of Colorado Boulder, Bachelor Of Arts (B.A.)
January 1978 - January 1982
Frequently Asked Questions about Margaret Karow
What is Margaret Karow email address?
Margaret Karow's primary email address is ******@amgen.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Margaret Karow work for?
Margaret Karow is a Founder and Chief Development Office at Xilio Therapeutics, Inc., a company specializing in Commercial physical research.
Where Margaret Karow graduated from?
Margaret Karow holds a degree in Cvm Biology from University of Utah School of Medicine.
How can I directly contact Margaret Karow?
To contact Margaret Karow directly, you can use the email address ******@amgen.com. Complete contact information is available upon registration with Muraena.
Who is Margaret Karow?
Margaret Karow is a seasoned biopharmaceutical expert with over 25 years of experience in protein therapeutics development. As the Founder and Chief Development Officer at Tentarix Biotherapeutics, she has a proven track record of leading innovative projects and achieving significant funding milestones. Her previous roles include serving as the Chief Scientific Officer at Gensun Biopharma and as Senior Vice President of Pre-Clinical Development at Xilio Therapeutics, where she played a pivotal role in advancing therapeutic candidates. Margaret's extensive background includes leadership positions at Amgen, where she oversaw various departments focused on biologics and biosimilars. She began her career at Regeneron, contributing to groundbreaking work in immunology and antibody development. Known for her strategic mindset and technical expertise, Margaret is passionate about advancing therapeutic solutions in the life sciences sector.
Margaret`s contact details
******@amgen.com
******@tentarix.com
Colleagues
Senior Vice President, Corporate Development and Program Leadership
Senior Vice President Clinical Operations
Senior Vice President Tech Ops
Director
Chief Development Officer (CDO)
Vice President Clinical Science and Pharmacovigilance
Chief Medical Officer
Chief Scientific Officer
Chief Financial Officer and Chief Operating Officer